Horn Patrick Taylor 4
4 · ALBIREO PHARMA, INC. · Filed Jul 26, 2021
Insider Transaction Report
Form 4
Horn Patrick Taylor
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-07-22$34.13/sh−90$3,072→ 12,450 total
Footnotes (2)
- [F1]Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F2]Represents 5,075 shares of common stock and 7,375 restricted stock units. Includes 647 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on May 31, 2021.